Stenocare A/S

STENO

DK0061078425

Pharmaceuticals

Delayed Nasdaq Copenhagen Other stock markets 04:56:52 31/05/2024 pm IST			5-day change	1st Jan Change
4.47 ^DKK	-1.32%		-10.24%	+75.98%

23/05	Stenocare A/S Launches Next Generation Medical Cannabis Oil Product in Australia	CI
02/05	Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

STENOCARE A/S Announces Resignation of Ian Abramowitz from Board of Directors, with Effect from September 5, 2019

September 06, 2019 at 01:28 am IST

STENOCARE A/S announced that Ian Abramowitz has informed the Board of Directors that he is stepping down from his seat at the Board of STENOCARE, with effect from September 5, 2019.

Latest news about Stenocare A/S

Stenocare A/S Launches Next Generation Medical Cannabis Oil Product in Australia	23/05	CI
Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Stenocare A/S Announces That the New STENOCARETHC/CBD Medical Cannabis Oil Product Available for Sale in Denmark	18/04	CI
Stenocare A/S to Deliver New Medical Cannabis Oil Product for Australian Patients	12/03	CI
Stenocare Gets Nod for Sale of Medical Cannabis Oil Product in Denmark	26/02	MT
STENOCARE Receives Approval to Sell a New Medical Cannabis Oil Product in Denmark	26/02	CI
Stenocare A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02	CI
Stenocare A/S Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
Danish Medical Cannabis Group Stenocare Secures Refinancing Deal	12/01	MT
Stenocare A/S Reaches Refinancing Agreement Covering All Existing Debt of DKK 8.2 Million	12/01	CI
Stenocare Aims to Boost Sales in Australia via Quest Biotech Pharma Team up	14/12	MT
Stenocare A/S Enters into A New Partnership Agreement with Quest Biotech Pharma	14/12	CI
Stenocare A/S Expands Presence with New Medical Cannabis Oil Product	23/11	CI
Stenocare A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Stenocare to Supply, Sell Medical Cannabis in Germany; Shares Surge	30/23/30	MT
Stenocare Ready to Ship Medical Cannabis to German Patients	30/23/30	CI
Stenocare A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17	CI
Stenocare A/S Provides Sales Guidance for the Year 2023	17/23/17	CI
Stenocare A/S Provides Update on Their Strong Danish Product Pipeline	27/23/27	CI
Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	20/23/20	CI
Stenocare Raises DKK10.7 Million from Oversubscribed Rights Offering; Falls 10%	12/23/12	MT
Denmark’s Stenocare Teams Up with International Partner for New Cannabis Oil Product	02/23/02	MT
Stenocare A/S Reports on Significant Progress in Development of Its New Innovative Medical Cannabis Product	02/23/02	CI
Stenocare A/S Launches IT-Platform for Online Clinics	30/23/30	CI
Denmark's Stenocare Wins Regulatory Nod to Enter German Market	25/23/25	MT

STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Companyâs business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
STENOCARE A/S	+75.98%	11.95M
DONG-E-E-JIAO CO.,LTD.	+38.97%	6.09B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.28%	4.14B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.48%	3.23B
TASLY PHARMACEUTICAL GROUP CO., LTD	-19.51%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.29%	2.39B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.43%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.71%	1.57B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.15%	1.55B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.86%	1.5B

Alternative Medicine

Stenocare A/S

Equities

STENO

DK0061078425

Pharmaceuticals

STENOCARE A/S Announces Resignation of Ian Abramowitz from Board of Directors, with Effect from September 5, 2019

Latest news about Stenocare A/S

Chart Stenocare A/S

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine